What is the recommended conversion dose from Adderall (amphetamine and dextroamphetamine) 30mg Immediate Release (IR) to Focalin (dexmethylphenidate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting Adderall 30mg IR to Focalin

The recommended conversion from Adderall 30mg IR to Focalin (dexmethylphenidate) is 15mg daily, typically divided into two doses of 7.5mg twice daily.

Conversion Rationale

  • Dexmethylphenidate (Focalin) is approximately twice as potent as methylphenidate, and methylphenidate is roughly equivalent to amphetamine in clinical potency 1, 2
  • Based on clinical studies, Adderall (mixed amphetamine salts) should be converted to Focalin at approximately a 2:1 ratio, meaning 30mg of Adderall IR would convert to approximately 15mg of Focalin IR 2, 3
  • The American Academy of Child and Adolescent Psychiatry supports this conversion ratio in clinical practice 4

Dosing Schedule Recommendations

  • Focalin IR should be administered twice daily due to its 6-hour duration of action, compared to Adderall IR's similar duration 2
  • The 15mg daily dose should be divided into two doses of 7.5mg, typically given in the morning and early afternoon to minimize sleep disturbances 4, 5
  • If 7.5mg tablets are not available, 5mg tablets can be used with slight dose adjustment (5mg twice daily with a 5mg midday supplemental dose if needed) 6

Titration Considerations

  • After initial conversion, allow at least one week to evaluate clinical response before making dose adjustments 4
  • If symptom control is inadequate, the dose can be increased in 2.5-5mg increments weekly, not exceeding the maximum recommended daily dose of 20mg for Focalin IR 5, 3
  • Clinical efficacy should be monitored using standardized rating scales when possible 6

Monitoring Parameters

  • Blood pressure and pulse should be checked at baseline and quarterly during treatment 4, 6
  • Weight should be monitored at each visit to assess for appetite suppression 4
  • Evaluate for common side effects including insomnia, decreased appetite, headaches, and irritability 4, 7

Special Considerations

  • Focalin IR tablets can be safely cut for precise dose titration when finding the optimal therapeutic dose 6
  • For patients with difficulty swallowing tablets, Focalin XR capsules can be opened and sprinkled on applesauce as an alternative 3
  • If Focalin IR is not effective at the maximum recommended dose, consider switching to Focalin XR for once-daily dosing and potentially improved adherence 5, 3

Common Pitfalls to Avoid

  • Starting at too high a dose, which can lead to unnecessary side effects and decreased medication adherence 4
  • Not allowing sufficient time between dose increases to evaluate response 4
  • Failing to systematically assess both benefits and side effects during titration 4, 6
  • Continuing to increase the dose beyond maximum recommendations when not effective - consider alternative medications instead 4, 6

References

Research

Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2014

Guideline

Adderall Dosing Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Maximum Recommended Doses of Adderall XR and IR for ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Adderall® (amphetamine-dextroamphetamine) toxicity.

Topics in companion animal medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.